Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Publication year range
4.
Eur J Clin Microbiol Infect Dis ; 43(1): 55-59, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37924444

ABSTRACT

Human sapovirus (HuSaV) is a common cause of gastroenteritis worldwide and is responsible for approximately 4% of acute gastroenteritis episodes in Europe. As reported with norovirus, patients with immunocompromised states are at increased risk of developing HuSaV infection, which can lead to persistent diarrhea and chronic viral shedding in some individuals. Chronic infections are incompletely investigated in these patients, and, due to the lack of specific treatment for HuSaV infection, different clinical approaches were carried out in order to provide further evidence on clinical evolution of these patients with different treatments. In this retrospective study, we report five immunocompromised pediatric patients with recurrent diarrhea caused by HuSaV and long-term viral shedding. Stool samples were analyzed by real-time PCR and tested for enteropathogenic viruses and bacteria and protozoa. Among transplant recipients, reduction of immunosuppressant therapy led to clinical improvement and relief of symptoms, maintaining a balance between managing the infection and preventing graft rejection. Nitazoxanide for 14 days was only used in one of these patients, showing to be an effective therapy to achieve reduction in time to resolution of symptoms. Neither nitazoxanide nor modification of immunosuppressant therapy could avoid recurrences. Further investigations are needed to develop new approaches that can both clear the infection and avoid persistent diarrhea in these patients.


Subject(s)
Adenovirus Infections, Human , Caliciviridae Infections , Enterovirus Infections , Gastroenteritis , Sapovirus , Humans , Child , Infant , Sapovirus/genetics , Retrospective Studies , Caliciviridae Infections/diagnosis , Gastroenteritis/diagnosis , Diarrhea/diagnosis , Immunosuppressive Agents , Feces
5.
Anaerobe ; 84: 102803, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37984560

ABSTRACT

Infections from anaerobic microorganisms result from breached mucosal barriers, posing a significant mortality risk. A retrospective study at Hospital Universitario La Paz (Madrid) from 2010 to 2022 analyzed 491 (6.17 %) anaerobic bacteremia cases out of 7956 significant bacteremia cases among 171,833 blood culture requests. Bacteroides fragilis was the most frequently isolated species (28.3 %), followed by Clostridium perfringens (13.6 %). B. fragilis showed good susceptibility to amoxicillin/ clavulanic acid (86 %), piperacillin/tazobactam (86 %), and metronidazole (87.7 %). In general, non-fragilis Bacteroides species showed low susceptibility to penicillin (7 %), amoxicillin (17.5 %), and clindamycin (64.9 %). Of our 13 non-perfringens Clostridium isolates, four exhibited resistance to penicillin and four showed resistance to clindamycin. Lactobacillus species were highly susceptible to antibiotics tested. Prevotella spp. showed low susceptibility to penicillin (20 %), amoxicillin (20 %), and clindamycin (40 %). The study contributes valuable data for monitoring and improving anaerobic bacteremia treatment.


Subject(s)
Bacteremia , Bacteria, Anaerobic , Humans , Clindamycin , Retrospective Studies , Tertiary Care Centers , Microbial Sensitivity Tests , Anti-Bacterial Agents/pharmacology , Bacteremia/drug therapy , Bacteremia/microbiology , Piperacillin, Tazobactam Drug Combination , Bacteroides fragilis , Amoxicillin , Amoxicillin-Potassium Clavulanate Combination , Clostridium perfringens
SELECTION OF CITATIONS
SEARCH DETAIL
...